Limbus AI

Limbus AI is a Canadian healthcare technology company based in Regina, Saskatchewan, founded in 2017. The company specializes in AI-driven automated contouring software designed for radiation therapy planning in cancer care. Limbus AI develops machine learning-based products that enhance efficiency and clinical workflows, allowing for faster and more accurate treatment plans without the need for cloud data transfer. In May 2024, Limbus AI was acquired by Radformation.

The flagship product, Limbus Contour, is an AI-powered automatic contouring tool that has received FDA 510(k) clearance and CE Mark certification. It generates clinical-grade contours in seconds, significantly reducing planning times for thousands of patients in North America. The software integrates seamlessly into existing treatment planning systems and supports multimodality AI contouring. Limbus AI focuses on improving cancer care through secure, on-premises processing, ensuring patient data remains protected while delivering rapid results. The company serves healthcare facilities, particularly radiation therapy departments, across North America and Europe.